<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Justinebiel - Latest News</title>
<link href="https://news.prfree.org/rss/justinebiel/latest.xml"></link>
<updated>2026-07-22T18:18:04+00:00</updated>
<id>urn:uuid:b7830b8c-9082-3926-034b-2667f8b59a77</id>
<entry>
<title>MRI Systems Market Segmentation Overview 2017-2025</title>
<link href="https://news.prfree.org/@justinebiel/mri-systems-market-segmentation-overview-2017-2025-eqmj8r3j6mr6"></link>
<id>urn:uuid:16576b77-1c16-0e80-a8d0-cfcf1d76fd2b</id>
<summary type="html"><![CDATA[The global MRI systems market segments is segmented on the basis of architecture, field-strength, technology, and applications.]]></summary>
<updated>2017-08-08T09:18:47+00:00</updated>
</entry>
<entry>
<title>Primary Biliary Cirrhosis Market- Company Profiles and Competitive Landscape Analysis Report</title>
<link href="https://news.prfree.org/@justinebiel/primary-biliary-cirrhosis-market-company-profiles-and-competitive-landscape-analysis-report-ypm4rpbpym85"></link>
<id>urn:uuid:8fd3972f-b706-fbc6-ae0b-1bbcdd9ce0af</id>
<summary type="html"><![CDATA[The Primary Biliary Cirrhosis Market report includes information of marketed products including their product description, patent details, forecasted sales till 2020]]></summary>
<updated>2017-08-03T09:55:40+00:00</updated>
</entry>
<entry>
<title>Multiple Myeloma Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/multiple-myeloma-pipeline-therapeutics-report-for-companies-and-drug-profile-in-h1-2017-n6ma7d83ymad"></link>
<id>urn:uuid:df8b1329-ee47-4dcc-866b-28c0984ac78c</id>
<summary type="html"><![CDATA[The pipeline guide provides a snapshot of the global therapeutic landscape of Multiple Myeloma (Kahler Disease) (Oncology).]]></summary>
<updated>2017-07-11T10:06:21+00:00</updated>
</entry>
<entry>
<title>Peripheral Nerve Sheath Tumor Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/peripheral-nerve-sheath-tumor-pipeline-therapeutics-report-for-companies-and-drug-profile-in-h1-2017-86kp6yypakr4"></link>
<id>urn:uuid:94798526-9bcf-0724-6a30-e09f42754042</id>
<summary type="html"><![CDATA[The Peripheral Nerve Sheath Tumor Pipeline guide reviews latest news related to pipeline therapeutics for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) (Oncology).]]></summary>
<updated>2017-07-10T13:38:38+00:00</updated>
</entry>
<entry>
<title>Presbyopia Pipeline Therapeutics by Target, Mechanism of Action in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/presbyopia-pipeline-therapeutics-by-target-mechanism-of-action-in-h1-2017-6rmyann7ymb4"></link>
<id>urn:uuid:890d3873-8e3a-885d-14c5-c030002cd3e2</id>
<summary type="html"><![CDATA[The Presbyopia pipeline guide reviews key companies involved in Presbyopia (Ophthalmology) therapeutics and enlists all their major and minor projects.]]></summary>
<updated>2017-07-10T11:31:19+00:00</updated>
</entry>
<entry>
<title>Rhino Conjunctivitis Pipeline Therapeutics Assessment 2017</title>
<link href="https://news.prfree.org/@justinebiel/rhino-conjunctivitis-pipeline-therapeutics-assessment-2017-3rm6yxd43keq"></link>
<id>urn:uuid:a70b4526-1c26-0d71-0ca1-b1f002f1a183</id>
<summary type="html"><![CDATA[Rhino-Conjunctivitis - Pipeline Review, H1 2017, provides an overview of the Rhino-Conjunctivitis (Ophthalmology) pipeline landscape.]]></summary>
<updated>2017-07-07T12:43:37+00:00</updated>
</entry>
<entry>
<title>Artificial Grass Turf Market Tremendous Growth in Near Future during 2017-2022 in Depth</title>
<link href="https://news.prfree.org/@justinebiel/artificial-grass-turf-market-tremendous-growth-in-near-future-during-2017-2022-in-depth-86kpneqwakr4"></link>
<id>urn:uuid:f1287fc5-9a4f-fdca-ed50-8ad8bd0a64ed</id>
<summary type="html"><![CDATA[Global Artificial Grass Turf Market by Manufacturers, Regions, Type and Application, Forecast to 2022 is a professional and in-depth study on the current state of the Artificial Grass Turf industry.]]></summary>
<updated>2017-06-23T10:19:35+00:00</updated>
</entry>
<entry>
<title>Progressive Supranuclear Palsy Pipeline Reviews of Companies and Drug Profiles Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/progressive-supranuclear-palsy-pipeline-reviews-of-companies-and-drug-profiles-market-report-h1-2017-eqm3pxqpakdy"></link>
<id>urn:uuid:88cba4e2-1ef3-a14d-3c01-5fe02e99d4aa</id>
<summary type="html"><![CDATA[The Progressive Supranuclear Palsy pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.]]></summary>
<updated>2017-06-20T13:11:37+00:00</updated>
</entry>
<entry>
<title>Canavan Disease Pipeline Market Report Analyzing Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/canavan-disease-pipeline-market-report-analyzing-report-h1-2017-3bmna6b4pk6p"></link>
<id>urn:uuid:d003960d-559c-03eb-574b-b08245b67bcf</id>
<summary type="html"><![CDATA[The pipeline guide evaluates Canavan Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.]]></summary>
<updated>2017-06-20T10:18:31+00:00</updated>
</entry>
<entry>
<title>Hypertension Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/hypertension-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-ypm44jeeem85"></link>
<id>urn:uuid:10a67656-1d30-2685-ddba-4ec216bf4035</id>
<summary type="html"><![CDATA[The pipeline guide reviews pipeline therapeutics for Hypertension (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.]]></summary>
<updated>2017-06-19T13:20:39+00:00</updated>
</entry>
<entry>
<title>Gaucher Disease Pipeline Therapeutics Development Market Report in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/gaucher-disease-pipeline-therapeutics-development-market-report-in-h1-2017-3bmna6yq3k6p"></link>
<id>urn:uuid:18844e75-8494-6958-faf7-42cc4f357cb1</id>
<summary type="html"><![CDATA[The Gaucher Disease pipeline guide reviews latest news related to pipeline therapeutics for Gaucher Disease (Genetic Disorders)]]></summary>
<updated>2017-06-16T12:11:04+00:00</updated>
</entry>
<entry>
<title>Short Bowel Syndrome Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/short-bowel-syndrome-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-eqm3pxnybkdy"></link>
<id>urn:uuid:7d2741a1-ee02-590f-5272-be01d8ea91f9</id>
<summary type="html"><![CDATA[Short Bowel Syndrome Pipeline market report provides a snapshot of the global therapeutic landscape of Short Bowel Syndrome . Short Bowel Syndrome - Pipeline Review, H1 2017 is a new market research report added to ReportsnReports.com.]]></summary>
<updated>2017-06-15T11:49:06+00:00</updated>
</entry>
<entry>
<title>Reflux Esophagitis Pipeline Therapeutics Report for Companies and Drug Profile in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/reflux-esophagitis-pipeline-therapeutics-report-for-companies-and-drug-profile-in-h1-2017-yrkdwjxp6m5x"></link>
<id>urn:uuid:44be3730-d869-63df-3e6a-aee724a018a1</id>
<summary type="html"><![CDATA[Reflux Esophagitis - Pipeline Market Review, H1 2017 report provides an overview of the Reflux Esophagitis Ophthalmology pipeline landscape. The Reflux Esophagitis pipeline guide encapsulates all the dormant and discontinued pipeline projects.]]></summary>
<updated>2017-06-14T10:33:07+00:00</updated>
</entry>
<entry>
<title>Fatigue Pipeline Market Report of Drugs under Development by Stages, Targets and Molecules H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/fatigue-pipeline-market-report-of-drugs-under-development-by-stages-targets-and-molecules-h1-2017-3bmna4dx3k6p"></link>
<id>urn:uuid:1f2cdd33-6a87-cf6b-04f0-4da5254f917c</id>
<summary type="html"><![CDATA[The pipeline guide evaluates Fatigue (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.]]></summary>
<updated>2017-06-13T14:21:57+00:00</updated>
</entry>
<entry>
<title>Market Report on Dilated Cardiomyopathy Pipeline in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/market-report-on-dilated-cardiomyopathy-pipeline-in-h1-2017-qak7qdde4ky3"></link>
<id>urn:uuid:82ad273d-c90a-928f-b262-c91efd42e7e5</id>
<summary type="html"><![CDATA[The Dilated Cardiomyopathy pipeline guide evaluates Dilated Cardiomyopathy (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.]]></summary>
<updated>2017-06-12T12:42:31+00:00</updated>
</entry>
<entry>
<title>Chronic Lymphocytic Leukemia Pipeline Therapeutics Development Market Report in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/chronic-lymphocytic-leukemia-pipeline-therapeutics-development-market-report-in-h1-2017-6rmyq65nymb4"></link>
<id>urn:uuid:45c661f6-a997-c693-a0cb-0c0ec0d444f7</id>
<summary type="html"><![CDATA[Chronic Lymphocytic Leukemia pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.]]></summary>
<updated>2017-06-08T12:09:26+00:00</updated>
</entry>
<entry>
<title>Atrial Fibrillation Pipeline Market Reviews in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/atrial-fibrillation-pipeline-market-reviews-in-h1-2017-b7kxewqj7mry"></link>
<id>urn:uuid:d905ffe8-5297-a6f2-0cce-a06eff125633</id>
<summary type="html"><![CDATA[Atrial Fibrillation Pipeline therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.]]></summary>
<updated>2017-06-06T09:27:11+00:00</updated>
</entry>
<entry>
<title>Global Benign Prostatic Hyperplasia Pipeline Overview of Companies and Drug Profile in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/global-benign-prostatic-hyperplasia-pipeline-overview-of-companies-and-drug-profile-in-h1-2017-3bmna4y84k6p"></link>
<id>urn:uuid:bdb061d6-861a-df31-4ff1-277ff906dc4c</id>
<summary type="html"><![CDATA[The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.]]></summary>
<updated>2017-06-05T12:09:59+00:00</updated>
</entry>
<entry>
<title>Diabetic Retinopathy Pipeline Therapeutics Development Report in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/diabetic-retinopathy-pipeline-therapeutics-development-report-in-h1-2017-6rmyq684ymb4"></link>
<id>urn:uuid:b21e5b23-b7b4-683c-c634-1e5d4087f2bb</id>
<summary type="html"><![CDATA[Diabetic Retinopathy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Diabetic Retinopathy (Metabolic Disorders), complete with analysis.]]></summary>
<updated>2017-06-02T13:32:22+00:00</updated>
</entry>
<entry>
<title>H1 2017 Ankylosing Spondylitis Pipeline Overview of Market Companies and Drug Profile Report</title>
<link href="https://news.prfree.org/@justinebiel/h1-2017-ankylosing-spondylitis-pipeline-overview-of-market-companies-and-drug-profile-report-eqmjd65edmr6"></link>
<id>urn:uuid:4f5347ab-d319-0097-6f78-858c8d2b68c3</id>
<summary type="html"><![CDATA[Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2017, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) (Musculoskeletal Disorders) pipeline landscape.]]></summary>
<updated>2017-06-02T12:58:18+00:00</updated>
</entry>
<entry>
<title>Osteonecrosis Pipeline Market Report of Global Industry Analysis and Opportunity Assessment H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/osteonecrosis-pipeline-market-report-of-global-industry-analysis-and-opportunity-assessment-h1-2017-p7ke65bybmwx"></link>
<id>urn:uuid:5907d33f-fdfc-cf9a-eda4-9e0d0e72c6db</id>
<summary type="html"><![CDATA[The pipeline guide reviews latest news related to pipeline therapeutics for Osteonecrosis (Musculoskeletal Disorders)]]></summary>
<updated>2017-06-01T13:50:04+00:00</updated>
</entry>
<entry>
<title>Dermatomyositis Pipeline Landscape H1 2017 Report</title>
<link href="https://news.prfree.org/@justinebiel/dermatomyositis-pipeline-landscape-h1-2017-report-jekra6j4pmxr"></link>
<id>urn:uuid:ddc5ebf3-f505-6812-0036-2d669c7dc923</id>
<summary type="html"><![CDATA[Dermatomyositis - Pipeline Review, H1 2017 is a new market research report added to ReportsnReports.com as a Pharmaceutical and Healthcare disease pipeline guide.]]></summary>
<updated>2017-06-01T13:26:01+00:00</updated>
</entry>
<entry>
<title>Hemophilia A Pipeline Therapeutics Assessment Report 2017</title>
<link href="https://news.prfree.org/@justinebiel/hemophilia-a-pipeline-therapeutics-assessment-report-2017-ypm44ndnem85"></link>
<id>urn:uuid:38bb2557-9d7a-79b1-0a69-1a9132b3b267</id>
<summary type="html"><![CDATA[Hemophilia A pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages]]></summary>
<updated>2017-05-31T11:52:13+00:00</updated>
</entry>
<entry>
<title>Cancer Pain Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/cancer-pain-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-eqmjdj67ymr6"></link>
<id>urn:uuid:bde9bf4c-e33e-c3b9-b736-a818ee340905</id>
<summary type="html"><![CDATA[The Cancer Pain Pipeline report covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.]]></summary>
<updated>2017-05-31T10:15:08+00:00</updated>
</entry>
<entry>
<title>Dyskinesia Pipeline for Drug Profile and Companies in H1 2017 Report</title>
<link href="https://news.prfree.org/@justinebiel/dyskinesia-pipeline-for-drug-profile-and-companies-in-h1-2017-report-3rm6y7addkeq"></link>
<id>urn:uuid:7d9c08fc-3736-3c24-13ec-9a3b39b12278</id>
<summary type="html"><![CDATA[The pipeline guide evaluates Dyskinesia (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.]]></summary>
<updated>2017-05-30T12:48:39+00:00</updated>
</entry>
<entry>
<title>Systemic Lupus Erythematosus Pipeline Market Therapeutics Development Overview for H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/systemic-lupus-erythematosus-pipeline-market-therapeutics-development-overview-for-h1-2017-6rmyqydpamb4"></link>
<id>urn:uuid:a9907564-e907-4b2a-34ac-a1b78346a087</id>
<summary type="html"><![CDATA[Systemic Lupus Erythematosus - Pipeline Review, H1 2017, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.]]></summary>
<updated>2017-05-30T11:18:40+00:00</updated>
</entry>
<entry>
<title>Pipeline Review of Muscular Dystrophy for H1 2017 in Market Research Report</title>
<link href="https://news.prfree.org/@justinebiel/pipeline-review-of-muscular-dystrophy-for-h1-2017-in-market-research-report-3rmw6xdyqkn4"></link>
<id>urn:uuid:5029f024-513b-4ff3-a364-b4b12c649735</id>
<summary type="html"><![CDATA[The Muscular Dystrophy pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.]]></summary>
<updated>2017-05-30T09:56:14+00:00</updated>
</entry>
<entry>
<title>Pipeline Report Aplastic Anemia Market Stage Development by Companies and Drug</title>
<link href="https://news.prfree.org/@justinebiel/pipeline-report-aplastic-anemia-market-stage-development-by-companies-and-drug-eqmjdj4r7mr6"></link>
<id>urn:uuid:32ae098f-0321-a35f-e3e5-2bbe2d1e7ef0</id>
<summary type="html"><![CDATA[Aplastic Anemia - Pipeline Review, H1 2017, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape.]]></summary>
<updated>2017-05-29T13:23:36+00:00</updated>
</entry>
<entry>
<title>H1 Adrenoleukodystrophy Pipeline Therapeutics Assessment Report 2017</title>
<link href="https://news.prfree.org/@justinebiel/h1-adrenoleukodystrophy-pipeline-therapeutics-assessment-report-2017-y7m8bq8n4me8"></link>
<id>urn:uuid:7f3a70b5-fe6d-8cdc-9a12-042e56da2f23</id>
<summary type="html"><![CDATA[The Adrenoleukodystrophy  guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.]]></summary>
<updated>2017-05-29T12:12:36+00:00</updated>
</entry>
<entry>
<title>Pipeline Cytomegalovirus (HHV-5) Infections Market in Therapeutics Development in H1 2017 Report</title>
<link href="https://news.prfree.org/@justinebiel/pipeline-cytomegalovirus-hhv-5-infections-market-in-therapeutics-development-in-h1-2017-report-eqmjdjed6mr6"></link>
<id>urn:uuid:1be66c0f-da40-0b61-4c25-f61e3d9ac169</id>
<summary type="html"><![CDATA[The covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery.]]></summary>
<updated>2017-05-26T13:26:59+00:00</updated>
</entry>
<entry>
<title>Amyotrophic Lateral Sclerosis Pipeline Market Reviews in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/amyotrophic-lateral-sclerosis-pipeline-market-reviews-in-h1-2017-y7m8bqpb4me8"></link>
<id>urn:uuid:6b12625d-d138-9bb8-821b-60b8fe9018d5</id>
<summary type="html"><![CDATA[The Amyotrophic Lateral Sclerosis pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.]]></summary>
<updated>2017-05-26T13:06:50+00:00</updated>
</entry>
<entry>
<title>Nephrotic Syndrome Market – Pipeline Overview of Drug Profile in H1 2017 Report</title>
<link href="https://news.prfree.org/@justinebiel/diabetic-nephropathy-market-pipeline-overview-of-drug-profile-in-h1-2017-report-ypm44nebdm85"></link>
<id>urn:uuid:89c800bc-b914-3911-df59-04f64f6b49a6</id>
<summary type="html"><![CDATA[Nephrotic Syndrome - Pipeline Market Review, H1 2017 report provides an overview of the Nephrotic Syndrome Ophthalmology pipeline landscape. The Nephrotic Syndrome pipeline guide encapsulates all the dormant and discontinued pipeline projects.]]></summary>
<updated>2017-05-25T10:21:00+00:00</updated>
</entry>
<entry>
<title>Myocardial Ischemia Pipeline Market Reviews in H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/myocardial-ischemia-pipeline-market-reviews-in-h1-2017-b7kxejyw7mry"></link>
<id>urn:uuid:4a13ad41-05bf-7fd4-dc77-6278c93d0f88</id>
<summary type="html"><![CDATA[The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects.]]></summary>
<updated>2017-05-25T09:19:48+00:00</updated>
</entry>
<entry>
<title>Vitiligo Pipeline Therapeutics Assessment Report</title>
<link href="https://news.prfree.org/@justinebiel/vitiligo-pipeline-therapeutics-assessment-report-3bmna7re4k6p"></link>
<id>urn:uuid:d3fbce18-e0c6-e3a9-da4b-1002f5f76295</id>
<summary type="html"><![CDATA[The Vitiligo report covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 2, 2 and 4 respectively.]]></summary>
<updated>2017-05-24T14:07:39+00:00</updated>
</entry>
<entry>
<title>Rosacea Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/rosacea-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-6rm5xa6npkw4"></link>
<id>urn:uuid:cece9a3b-239e-67f5-fb55-58ac0cae1f1b</id>
<summary type="html"><![CDATA[Rosacea (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.]]></summary>
<updated>2017-05-24T13:31:26+00:00</updated>
</entry>
<entry>
<title>Pipeline Review of Acne Vulgaris for H1 2017 in Market Research Report</title>
<link href="https://news.prfree.org/@justinebiel/pipeline-review-of-acne-vulgaris-for-h1-2017-in-market-research-report-3rmw6x7b4kn4"></link>
<id>urn:uuid:70878e42-c2b7-8bbb-7f33-41e1301611e7</id>
<summary type="html"><![CDATA[The  Acne Vulgaris pipeline guide reviews key companies involved in Acne Vulgaris (Dermatology) therapeutics and enlists all their major and minor projects.]]></summary>
<updated>2017-05-24T12:37:42+00:00</updated>
</entry>
<entry>
<title>Pheochromocytoma Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/pheochromocytoma-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-3rm6y7ydjkeq"></link>
<id>urn:uuid:63c015d7-a959-f6f1-1697-c49cb6e58bfa</id>
<summary type="html"><![CDATA[Pheochromocytoma - Pipeline Market Review, H1 2017 report provides an overview of the Pheochromocytoma Ophthalmology pipeline landscape. The Pheochromocytoma pipeline guide encapsulates all the dormant and discontinued pipeline projects.]]></summary>
<updated>2017-05-23T12:11:13+00:00</updated>
</entry>
<entry>
<title>Gastric Cancer Pipeline Analysis of Companies and Drug Profile Market Report H1 2017</title>
<link href="https://news.prfree.org/@justinebiel/gastric-cancer-pipeline-analysis-of-companies-and-drug-profile-market-report-h1-2017-p7ke656q7mwx"></link>
<id>urn:uuid:52331801-14a3-43d8-3f1e-514b1f0c41dd</id>
<summary type="html"><![CDATA[The Gastric Cancer pipeline report reviews key companies involved in Gastric Cancer (Oncology) therapeutics and enlists all their major and minor projects.]]></summary>
<updated>2017-05-23T09:51:31+00:00</updated>
</entry>
</feed>